Nicolas, J., Baber, U., & Mehran, R. (2020). TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention. Radcliffe Medical Media.
Cita Chicago Style (17a ed.)Nicolas, Johny, Usman Baber, y Roxana Mehran. TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention. Radcliffe Medical Media, 2020.
Cita MLA (8a ed.)Nicolas, Johny, et al. TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention. Radcliffe Medical Media, 2020.